Veraxa Biotech Holding AG (VRXA) Enterprise Value (2024 - 2025)
Veraxa Biotech Holding AG (VRXA) posted quarterly Enterprise Value of -$1.5 million for Q4 2025, up 75.91% year-over-year from -$862345.1 in Q4 2024, and up 75.91% quarter-over-quarter from -$6.3 million in Q4 2024.
Veraxa Biotech Holding AG (VRXA) Enterprise Value (2024 - 2025) Analysis & Trends
Veraxa Biotech Holding AG (VRXA) has reported Enterprise Value for 2 consecutive years, with -$1.5 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Enterprise Value rose 75.91% year-over-year to -$1.5 million; the TTM figure through Dec 2025 stood at -$1.5 million (up 75.91% YoY), while the FY2025 annual figure was -$1.5 million, up 75.91% from the prior year.
- Enterprise Value advanced to -$1.5 million in Q4 2025 per VRXA's latest filing, from -$6.3 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$1.5 million in Q4 2025 and bottomed at -$6.3 million in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.52 Mn |
| Dec 31, 2024 | -6.30 Mn |